Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05288777
Title Adjuvant Chemoradiation and Biomarkers of Response in High-risk Breast Cancer (Breast53)
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Virginia

breast cancer



Ado-trastuzumab emtansine

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Virginia Charlottesville Virginia 22903 United States Details
*Shaded cells indicate that there was no data available from for the field